Treatment of Actinic Keratosis With 5% KOH Solution (TAKKOH)
Prospective, Single-arm, Medical Device Investigation According to § 23b MPG [German Medical Devices Act] on Efficacy and Safety of Treatment of Actinic Keratosis With a 5% Potassium Hydroxide Solution (AKOHDerm)
Sponsor: Gesellschaft für Therapieforschung mbH
A observational or N/A phase clinical study on Actinic Keratoses, this trial is completed. The trial is conducted by Gesellschaft für Therapieforschung mbH and has accumulated 6 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Nov 2019 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Sep 2019 — Nov 2019 [monthly]
Active Not Recruiting
▶ Show 1 earlier version
-
Aug 2019 — Sep 2019 [monthly]
Active Not Recruiting
First recorded
Oct 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Gesellschaft für Therapieforschung mbH
- Infectopharm Arzneimittel GmbH
For direct contact, visit the study record on ClinicalTrials.gov .